TippingPoint Biosciences
Pre-clinicalPioneering new therapies for diseases of chromatin dysfunction. There is a necessity for new types of treatments in diseases like Pediatric Diffuse Midlines Glioma (DMG). Cancer, Chromatin, Health, new solutions.
Founded
2018
Focus
Small Molecules
About
Pioneering new therapies for diseases of chromatin dysfunction. There is a necessity for new types of treatments in diseases like Pediatric Diffuse Midlines Glioma (DMG). Cancer, Chromatin, Health, new solutions.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile